SynBiotic SE
XETRA SBX.DE
SynBiotic SE Return on Assets (ROA) for the year ending December 31, 2023: -30.44%
SynBiotic SE Return on Assets (ROA) is -30.44% for the year ending December 31, 2023, a 49.23% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
-
SynBiotic SE Return on Assets (ROA) for the year ending December 31, 2022 was -59.97%, a -178.28% change year over year.
-
SynBiotic SE Return on Assets (ROA) for the year ending December 31, 2021 was -21.55%, a -757.40% change year over year.
-
SynBiotic SE Return on Assets (ROA) for the year ending December 31, 2020 was -2.51%.
Key data
| Date | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) | Interest Coverage Ratio |
|---|
Market news
Loading...
XETRA: SBX.DE
| CEO | Mr. Daniel Kruse |
| IPO Date | Jan. 7, 2021 |
| Location | Germany |
| Headquarters | Innere Wiener Str. 14 |
| Employees | 55 |
| Sector | Health Care |
| Industries | |
Description
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email